nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—Constipation—Fludarabine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Entacapone—Pain—Fludarabine—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Entacapone—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Entacapone—Urinary tract disorder—Vincristine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Entacapone—Urethral disorder—Vincristine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Entacapone—Eye disorder—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Entacapone—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Entacapone—Hypersensitivity—Teniposide—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Entacapone—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Entacapone—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Entacapone—Flushing—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Entacapone—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Entacapone—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Entacapone—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Entacapone—Asthenia—Teniposide—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Entacapone—Malaise—Bleomycin—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Entacapone—Pruritus—Teniposide—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Entacapone—Leukopenia—Bleomycin—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Entacapone—Cardiac disorder—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Entacapone—Alopecia—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Entacapone—Body temperature increased—Fludarabine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Entacapone—Mental disorder—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Entacapone—Malnutrition—Carmustine—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Entacapone—Cough—Bleomycin—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Entacapone—Diarrhoea—Teniposide—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Entacapone—Chest pain—Bleomycin—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Entacapone—Myalgia—Bleomycin—lymphatic system cancer	0.00168	0.00168	CcSEcCtD
Entacapone—Alopecia—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Entacapone—Back pain—Carmustine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Entacapone—Discomfort—Bleomycin—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Entacapone—Mental disorder—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Entacapone—Alopecia—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Entacapone—Confusional state—Bleomycin—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Entacapone—Vision blurred—Carmustine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Entacapone—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Entacapone—Tremor—Carmustine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Entacapone—Oedema—Bleomycin—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Entacapone—Back pain—Vincristine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Entacapone—Vomiting—Teniposide—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Entacapone—Agitation—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Entacapone—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Entacapone—Asthenia—Fludarabine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Entacapone—Rash—Teniposide—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Entacapone—Dermatitis—Teniposide—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Entacapone—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Entacapone—Headache—Teniposide—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Entacapone—Pruritus—Fludarabine—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Entacapone—Back pain—Mitoxantrone—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Entacapone—Leukopenia—Carmustine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Entacapone—Anorexia—Bleomycin—lymphatic system cancer	0.00154	0.00154	CcSEcCtD
Entacapone—Agitation—Vincristine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Entacapone—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Entacapone—Hypotension—Bleomycin—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Entacapone—Diarrhoea—Fludarabine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Entacapone—Convulsion—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Entacapone—Hypertension—Carmustine—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Entacapone—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Entacapone—Nausea—Teniposide—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Entacapone—Vertigo—Vincristine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Entacapone—Hepatic failure—Methotrexate—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Entacapone—Leukopenia—Vincristine—lymphatic system cancer	0.00148	0.00148	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Entacapone—Chest pain—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Entacapone—Myalgia—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Entacapone—Anxiety—Carmustine—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Entacapone—Paraesthesia—Bleomycin—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Entacapone—Malaise—Mitoxantrone—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Entacapone—Dyspnoea—Bleomycin—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Entacapone—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Entacapone—Convulsion—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Entacapone—Hypertension—Vincristine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Entacapone—Confusional state—Carmustine—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Entacapone—Oedema—Carmustine—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Entacapone—Decreased appetite—Bleomycin—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Entacapone—Myalgia—Vincristine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Entacapone—Cough—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Entacapone—Vomiting—Fludarabine—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Entacapone—Convulsion—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Entacapone—Rash—Fludarabine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Entacapone—Dermatitis—Fludarabine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Entacapone—Hypertension—Mitoxantrone—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Entacapone—Pain—Bleomycin—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Entacapone—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Entacapone—Headache—Fludarabine—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Entacapone—Myalgia—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Entacapone—Chest pain—Mitoxantrone—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Entacapone—Anxiety—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Entacapone—Discomfort—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Entacapone—Oedema—Vincristine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Entacapone—Anorexia—Carmustine—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Entacapone—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Entacapone—Confusional state—Mitoxantrone—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Entacapone—Nervous system disorder—Vincristine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Entacapone—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Entacapone—Hypotension—Carmustine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Entacapone—Oedema—Mitoxantrone—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Entacapone—Nausea—Fludarabine—lymphatic system cancer	0.00131	0.00131	CcSEcCtD
Entacapone—Hyperhidrosis—Vincristine—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Entacapone—Shock—Mitoxantrone—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Entacapone—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Entacapone—Urticaria—Bleomycin—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Entacapone—Anorexia—Vincristine—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Entacapone—Body temperature increased—Bleomycin—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Entacapone—Insomnia—Carmustine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Entacapone—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Entacapone—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Entacapone—Paraesthesia—Carmustine—lymphatic system cancer	0.00127	0.00127	CcSEcCtD
Entacapone—Hypotension—Vincristine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Entacapone—Dyspnoea—Carmustine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Entacapone—Somnolence—Carmustine—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Entacapone—Anorexia—Mitoxantrone—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Entacapone—Ataxia—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Entacapone—Decreased appetite—Carmustine—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Entacapone—Hypotension—Mitoxantrone—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Entacapone—Insomnia—Vincristine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Entacapone—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Entacapone—Paraesthesia—Vincristine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Entacapone—Constipation—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Entacapone—Pain—Carmustine—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Entacapone—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Entacapone—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Entacapone—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Entacapone—Decreased appetite—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Entacapone—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Entacapone—Somnolence—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Entacapone—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Entacapone—Feeling abnormal—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Entacapone—Fatigue—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Entacapone—Asthenia—Bleomycin—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Entacapone—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Entacapone—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Entacapone—Pain—Vincristine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Entacapone—Constipation—Vincristine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Entacapone—Pruritus—Bleomycin—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Entacapone—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Entacapone—Fatigue—Mitoxantrone—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Entacapone—Constipation—Mitoxantrone—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Entacapone—Pain—Mitoxantrone—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Entacapone—Abdominal pain—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Entacapone—Body temperature increased—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Entacapone—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Entacapone—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Entacapone—Dysuria—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Entacapone—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Entacapone—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Entacapone—Body temperature increased—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Entacapone—Abdominal pain—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Entacapone—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Entacapone—Urticaria—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Entacapone—Hypersensitivity—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Entacapone—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Entacapone—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Entacapone—Pneumonia—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Entacapone—Vomiting—Bleomycin—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Entacapone—Depression—Methotrexate—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Entacapone—Rash—Bleomycin—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Entacapone—Dermatitis—Bleomycin—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Entacapone—Asthenia—Carmustine—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Entacapone—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000995	0.000995	CcSEcCtD
Entacapone—Hypersensitivity—Vincristine—lymphatic system cancer	0.000991	0.000991	CcSEcCtD
Entacapone—Sweating—Methotrexate—lymphatic system cancer	0.000981	0.000981	CcSEcCtD
Entacapone—Haematuria—Methotrexate—lymphatic system cancer	0.000976	0.000976	CcSEcCtD
Entacapone—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.000968	0.000968	CcSEcCtD
Entacapone—Epistaxis—Methotrexate—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Entacapone—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Entacapone—Asthenia—Vincristine—lymphatic system cancer	0.000965	0.000965	CcSEcCtD
Entacapone—Diarrhoea—Carmustine—lymphatic system cancer	0.000964	0.000964	CcSEcCtD
Entacapone—Nausea—Bleomycin—lymphatic system cancer	0.000959	0.000959	CcSEcCtD
Entacapone—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000955	0.000955	CcSEcCtD
Entacapone—Asthenia—Mitoxantrone—lymphatic system cancer	0.00094	0.00094	CcSEcCtD
Entacapone—Dizziness—Carmustine—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Entacapone—Haemoglobin—Methotrexate—lymphatic system cancer	0.000924	0.000924	CcSEcCtD
Entacapone—Diarrhoea—Vincristine—lymphatic system cancer	0.000921	0.000921	CcSEcCtD
Entacapone—Haemorrhage—Methotrexate—lymphatic system cancer	0.000919	0.000919	CcSEcCtD
Entacapone—Hepatitis—Methotrexate—lymphatic system cancer	0.000919	0.000919	CcSEcCtD
Entacapone—Pharyngitis—Methotrexate—lymphatic system cancer	0.000912	0.000912	CcSEcCtD
Entacapone—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000907	0.000907	CcSEcCtD
Entacapone—Urethral disorder—Methotrexate—lymphatic system cancer	0.000901	0.000901	CcSEcCtD
Entacapone—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000897	0.000897	CcSEcCtD
Entacapone—Vomiting—Carmustine—lymphatic system cancer	0.000896	0.000896	CcSEcCtD
Entacapone—Dizziness—Vincristine—lymphatic system cancer	0.00089	0.00089	CcSEcCtD
Entacapone—Rash—Carmustine—lymphatic system cancer	0.000889	0.000889	CcSEcCtD
Entacapone—Dermatitis—Carmustine—lymphatic system cancer	0.000888	0.000888	CcSEcCtD
Entacapone—Visual impairment—Methotrexate—lymphatic system cancer	0.000886	0.000886	CcSEcCtD
Entacapone—Headache—Carmustine—lymphatic system cancer	0.000883	0.000883	CcSEcCtD
Entacapone—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000869	0.000869	CcSEcCtD
Entacapone—Eye disorder—Methotrexate—lymphatic system cancer	0.000859	0.000859	CcSEcCtD
Entacapone—Vomiting—Vincristine—lymphatic system cancer	0.000855	0.000855	CcSEcCtD
Entacapone—Cardiac disorder—Methotrexate—lymphatic system cancer	0.000853	0.000853	CcSEcCtD
Entacapone—Rash—Vincristine—lymphatic system cancer	0.000848	0.000848	CcSEcCtD
Entacapone—Dermatitis—Vincristine—lymphatic system cancer	0.000848	0.000848	CcSEcCtD
Entacapone—Headache—Vincristine—lymphatic system cancer	0.000843	0.000843	CcSEcCtD
Entacapone—Nausea—Carmustine—lymphatic system cancer	0.000837	0.000837	CcSEcCtD
Entacapone—Vomiting—Mitoxantrone—lymphatic system cancer	0.000833	0.000833	CcSEcCtD
Entacapone—Rash—Mitoxantrone—lymphatic system cancer	0.000826	0.000826	CcSEcCtD
Entacapone—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000825	0.000825	CcSEcCtD
Entacapone—Headache—Mitoxantrone—lymphatic system cancer	0.000821	0.000821	CcSEcCtD
Entacapone—Alopecia—Methotrexate—lymphatic system cancer	0.000812	0.000812	CcSEcCtD
Entacapone—Mental disorder—Methotrexate—lymphatic system cancer	0.000805	0.000805	CcSEcCtD
Entacapone—Malnutrition—Methotrexate—lymphatic system cancer	0.0008	0.0008	CcSEcCtD
Entacapone—Nausea—Vincristine—lymphatic system cancer	0.000799	0.000799	CcSEcCtD
Entacapone—Dysgeusia—Methotrexate—lymphatic system cancer	0.000783	0.000783	CcSEcCtD
Entacapone—Nausea—Mitoxantrone—lymphatic system cancer	0.000778	0.000778	CcSEcCtD
Entacapone—Back pain—Methotrexate—lymphatic system cancer	0.000774	0.000774	CcSEcCtD
Entacapone—Vision blurred—Methotrexate—lymphatic system cancer	0.000754	0.000754	CcSEcCtD
Entacapone—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000742	0.000742	CcSEcCtD
Entacapone—Malaise—Methotrexate—lymphatic system cancer	0.000721	0.000721	CcSEcCtD
Entacapone—Vertigo—Methotrexate—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Entacapone—Leukopenia—Methotrexate—lymphatic system cancer	0.000716	0.000716	CcSEcCtD
Entacapone—Cough—Methotrexate—lymphatic system cancer	0.000698	0.000698	CcSEcCtD
Entacapone—Convulsion—Methotrexate—lymphatic system cancer	0.000693	0.000693	CcSEcCtD
Entacapone—Myalgia—Methotrexate—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Entacapone—Chest pain—Methotrexate—lymphatic system cancer	0.000681	0.000681	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000676	0.000676	CcSEcCtD
Entacapone—Discomfort—Methotrexate—lymphatic system cancer	0.000673	0.000673	CcSEcCtD
Entacapone—Confusional state—Methotrexate—lymphatic system cancer	0.000658	0.000658	CcSEcCtD
Entacapone—Nervous system disorder—Methotrexate—lymphatic system cancer	0.00064	0.00064	CcSEcCtD
Entacapone—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000639	0.000639	CcSEcCtD
Entacapone—Skin disorder—Methotrexate—lymphatic system cancer	0.000634	0.000634	CcSEcCtD
Entacapone—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000631	0.000631	CcSEcCtD
Entacapone—Anorexia—Methotrexate—lymphatic system cancer	0.000622	0.000622	CcSEcCtD
Entacapone—Hypotension—Methotrexate—lymphatic system cancer	0.00061	0.00061	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000595	0.000595	CcSEcCtD
Entacapone—Insomnia—Methotrexate—lymphatic system cancer	0.00059	0.00059	CcSEcCtD
Entacapone—Paraesthesia—Methotrexate—lymphatic system cancer	0.000586	0.000586	CcSEcCtD
Entacapone—Dyspnoea—Methotrexate—lymphatic system cancer	0.000582	0.000582	CcSEcCtD
Entacapone—Somnolence—Methotrexate—lymphatic system cancer	0.00058	0.00058	CcSEcCtD
Entacapone—Dyspepsia—Methotrexate—lymphatic system cancer	0.000575	0.000575	CcSEcCtD
Entacapone—Decreased appetite—Methotrexate—lymphatic system cancer	0.000568	0.000568	CcSEcCtD
Entacapone—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000564	0.000564	CcSEcCtD
Entacapone—Fatigue—Methotrexate—lymphatic system cancer	0.000563	0.000563	CcSEcCtD
Entacapone—Pain—Methotrexate—lymphatic system cancer	0.000558	0.000558	CcSEcCtD
Entacapone—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000538	0.000538	CcSEcCtD
Entacapone—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000534	0.000534	CcSEcCtD
Entacapone—Urticaria—Methotrexate—lymphatic system cancer	0.000519	0.000519	CcSEcCtD
Entacapone—Abdominal pain—Methotrexate—lymphatic system cancer	0.000516	0.000516	CcSEcCtD
Entacapone—Body temperature increased—Methotrexate—lymphatic system cancer	0.000516	0.000516	CcSEcCtD
Entacapone—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000481	0.000481	CcSEcCtD
Entacapone—Asthenia—Methotrexate—lymphatic system cancer	0.000468	0.000468	CcSEcCtD
Entacapone—Pruritus—Methotrexate—lymphatic system cancer	0.000462	0.000462	CcSEcCtD
Entacapone—Diarrhoea—Methotrexate—lymphatic system cancer	0.000447	0.000447	CcSEcCtD
Entacapone—Dizziness—Methotrexate—lymphatic system cancer	0.000432	0.000432	CcSEcCtD
Entacapone—Vomiting—Methotrexate—lymphatic system cancer	0.000415	0.000415	CcSEcCtD
Entacapone—Rash—Methotrexate—lymphatic system cancer	0.000412	0.000412	CcSEcCtD
Entacapone—Dermatitis—Methotrexate—lymphatic system cancer	0.000411	0.000411	CcSEcCtD
Entacapone—Headache—Methotrexate—lymphatic system cancer	0.000409	0.000409	CcSEcCtD
Entacapone—Nausea—Methotrexate—lymphatic system cancer	0.000388	0.000388	CcSEcCtD
